| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/12/1996 | CN1032019C Process for recombinant biocides using organisms |
| 06/11/1996 | US5525708 Stabilized protein cell growth and differentiation factors which activate mast cells |
| 06/11/1996 | US5525508 Purified antigen derived from homogenizing nematodes, extracting and chromatographing on wheat-germ lectin sepharose column |
| 06/11/1996 | US5525486 Genetic engineering |
| 06/11/1996 | US5525473 Using monoclonal antibodies |
| 06/11/1996 | US5525339 Presence in circulating bodily fluids provides diagnostic mechanism to determine onset of cerebral amyloid plaque formation |
| 06/11/1996 | US5525337 Detecting tumor cells by removing tissue or fluid sample, reacting with antibody capable of binding to surface antigen, detecting presence of antibody-antigen complex |
| 06/11/1996 | US5525336 Cosmetic containing comeocyte proteins and transglutaminase, and method of application |
| 06/11/1996 | EP0722489A4 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 06/11/1996 | CA2005950C Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein |
| 06/11/1996 | CA1338381C Minactivin - (plasminogen activator inhibitor-2) |
| 06/09/1996 | CA2164374A1 Method for quantitative determination of fas antigen |
| 06/07/1996 | WO1996017869A2 Interleukin-6 (il-6) antagonists |
| 06/07/1996 | CA2177837A1 Interleukin-6 (il-6) antagonists |
| 06/07/1996 | CA2141708A1 Nucleotide sequences encoding a novel stem cell marker protein, amino acid sequences of the protein, methods for expressing the protein, a composition of isolated protein, and antibodies specific to the protein |
| 06/06/1996 | WO1996017078A1 Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 06/06/1996 | WO1996017067A1 Method for secreting thrombopoietin polypeptides |
| 06/06/1996 | WO1996017063A1 Plasmids suitable for il-2 expression |
| 06/06/1996 | WO1996017060A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 06/06/1996 | WO1996017058A1 Denatured low-density lipoprotein receptor |
| 06/06/1996 | WO1996017057A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
| 06/06/1996 | WO1996017054A1 Method and compositions for reducing cholesterol absorption |
| 06/06/1996 | WO1996016990A1 Humanized antibodies to cd38 |
| 06/06/1996 | WO1996016988A1 Reagents and processes for targeting mutant epidermal growth factor receptors |
| 06/06/1996 | WO1996016979A1 Expressed chemokines, their production and uses |
| 06/06/1996 | WO1996016974A1 Pcr amplification of rearranged genomic variable regions of immunoglobulin genes |
| 06/06/1996 | WO1996016673A1 Method of promoting an immune response with a bispecific antibody |
| 06/06/1996 | WO1996016668A1 Novel hedgehog-derived polypeptides |
| 06/06/1996 | WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 06/06/1996 | CA2207869A1 Method of promoting an immune response with a bispecific antibody |
| 06/06/1996 | CA2206610A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 06/06/1996 | CA2206534A1 Pcr amplification of rearranged genomic variable regions of immunoglobulin genes |
| 06/06/1996 | CA2206526A1 Method and compositions for reducing cholesterol absorption |
| 06/06/1996 | CA2206305A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage |
| 06/06/1996 | CA2206113A1 Expressed chemokines, their production and uses |
| 06/05/1996 | EP0714988A2 Method for quantifying nucleic acids |
| 06/05/1996 | EP0714982A2 Hybrid proteins with fibrinolytic and thrombin inhibiting activity |
| 06/05/1996 | EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands |
| 06/05/1996 | EP0714665A2 Osteogenic devices |
| 06/05/1996 | EP0714513A1 Molecular clones producing recombinant dna antigens of the hards virus |
| 06/05/1996 | EP0714512A1 Marking of products to establish identity and source |
| 06/05/1996 | EP0714510A1 Natural killer cell-specific antigen and antibodies that identify the same |
| 06/05/1996 | EP0714445A1 Glucoamylase promoter obtained from neurospora crassa and its use in the production of heterologous polypeptides |
| 06/05/1996 | EP0714444A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 06/05/1996 | EP0714442A1 Recombinant alternaria alternata allergenes |
| 06/05/1996 | EP0714441A1 Recombinant cladosporium herbarum allergens |
| 06/05/1996 | EP0714440A1 T cell epitopes of ryegrass pollen allergen |
| 06/05/1996 | EP0714439A1 Recombinant humanized anti-human immunodeficiency virus antibody |
| 06/05/1996 | EP0714438A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 06/05/1996 | EP0714409A1 Antibodies |
| 06/05/1996 | EP0714408A1 Tryptase inhibitor |
| 06/05/1996 | EP0714406A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i |
| 06/05/1996 | EP0714405A1 Therapeutic and diagnostic agents for amyloidosis |
| 06/05/1996 | EP0714403A1 Aqueous multiple-phase isolation of polypeptide |
| 06/05/1996 | EP0714399A1 Hsv-2 ul26 gene, capsid proteins, immunoassays and protease inhibitors |
| 06/05/1996 | EP0577705B1 Method of enzymatic preparation of macrolactone |
| 06/05/1996 | EP0312542B1 Gamma, delta t cell receptor and methods for detection |
| 06/05/1996 | CN1031943C Method of purifying protein |
| 06/04/1996 | US5523393 BCL-2 proteins |
| 06/04/1996 | US5523287 Thrombin-inhibitory protein from assassin bugs |
| 06/04/1996 | US5523237 Protein preparations |
| 06/04/1996 | US5523215 Culturing host cell expressing desired protein in medium containing copper ions, disrupting, incubating insoluble fraction with chaotropic agent to dissolve contaminants, separating, treating insoluble fraction with reducing agent |
| 06/04/1996 | US5523209 Culturing a cell expressing a chimeric integrin and contacting with ligand that binds to reporter integrin only when activated |
| 06/04/1996 | US5523089 Borrelia antigen |
| 06/04/1996 | US5523085 Monoclonal antibody in destruction of small cell lung carcinoma |
| 06/04/1996 | CA2054551C Monoclonal antibodies to mite allergen and the use thereof |
| 05/31/1996 | CA2163925A1 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties |
| 05/30/1996 | WO1996016181A1 Expression plasmids for yeasts |
| 05/30/1996 | WO1996016180A1 Production of variant nisin |
| 05/30/1996 | WO1996016178A1 Immunogens for stimulating mucosal immunity |
| 05/30/1996 | WO1996016176A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4 |
| 05/30/1996 | WO1996016173A2 Modified proteinase inhibitors |
| 05/30/1996 | WO1996016166A1 Novel keratan sulfate hydrolase |
| 05/30/1996 | WO1996016088A1 Protein affecting katp channels |
| 05/30/1996 | WO1996016087A1 G-protein coupled receptor |
| 05/30/1996 | WO1996016075A1 Antibiotic cryptdin peptides and methods of their use |
| 05/30/1996 | WO1996015808A1 Method for making a medicament for treating secondary immunodeficiency |
| 05/30/1996 | WO1996015806A1 Human choline acetyltransferase |
| 05/30/1996 | WO1996015802A1 Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
| 05/30/1996 | WO1996012807A3 Hepatitis e virus antigens and uses therefor |
| 05/30/1996 | WO1996005300A3 Or-1 on orphan receptor belonging to the nuclear receptor family |
| 05/30/1996 | CA2205807A1 Fusion proteins with cytotoxic activity against cells overexpressing erbb2-4 |
| 05/30/1996 | CA2205356A1 Modified proteinase inhibitors |
| 05/30/1996 | CA2205204A1 Production of variant nisin |
| 05/30/1996 | CA2205130A1 Immunogens for stimulating mucosal immunity |
| 05/29/1996 | EP0713915A1 Hog cholera virus vaccine and diagnostic |
| 05/29/1996 | EP0713914A2 A regulatory gene for the expression of nitrile hydratase gene |
| 05/29/1996 | EP0713532A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 05/29/1996 | EP0713530A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
| 05/29/1996 | EP0713529A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-$g(b) FAMILY |
| 05/29/1996 | EP0713496A1 Fibrin-targeted inhibitors of thrombin |
| 05/29/1996 | EP0713495A1 Methods of enhancing bioactivity of chemokines |
| 05/29/1996 | EP0713493A1 Production of human hemoglobin in transgenic pigs |
| 05/29/1996 | EP0679089A4 Methods for promoting cartilage matrix formation. |
| 05/29/1996 | EP0558647B1 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/29/1996 | EP0469065B1 Recombinant antibody-toxin fusion protein |
| 05/29/1996 | CN1123326A Modified gene of human tumor necrotizing factor and its production process |
| 05/29/1996 | CN1123185A Immune couplet |
| 05/29/1996 | CN1031893C A mutant of protein for basic fibroblast growth factor, DNA and use thereof |